Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo".
Ferah Comert OnderNermin KahramanEsen Bellur AticiAli CagirHakan KandemirGizem TatarTugba Taskin TokGoknur KaraBekir KarligaSerdar DurdagiMehmet AyBulent OzpolatPublished in: ACS pharmacology & translational science (2021)
[This corrects the article DOI: 10.1021/acsptsci.1c00030.].
Keyphrases